Previous 10 |
BEIJING , Feb. 25, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced that the Company plans to release its fourth quarter and fi...
BEIJING , Jan. 7, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO ) ( "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today reiterated its previously revised full year 2018 forecast. Fu...
China Biologic Products, Inc. (CBPO) Q3 2018 Earnings Conference Call November 2, 2018 7:30 AM ET Executives Samuel Martin – Foote Group David Hui Li – Chairman Bing Li – Chief Executive Officer Ming Yin – Senior Vice President Ming Yang – C...
China Biologic Products (NASDAQ: CBPO ): Q3 Non-GAAP EPS of $0.96 misses by $0.13 ; GAAP EPS of $0.94. Revenue of $119.1M (+19.6% Y/Y) misses by $1.25M . Press Release More news on: China Biologic Products, Inc., Earnings news and commentary, Healthcare stocks news,
3Q18 Total Sales Up 21.9% YoY in RMB terms, or 19.6% YoY in USD terms; Non-GAAP Adjusted Net Income Down 12.7% YoY in RMB terms; Net Income Up 4.1% YoY to $32.9 Million Board of Di rectors Ap proves $100 M illion S hare R epurchase P rogram BEIJING , Nov. 1, 2018 /...
AAPL , ACIA , ACLS , AIRG , AIV , ALEX , AMH , ANET , AOSL , APPN , ARCB , ATGE , ATHN , ATR , ATRC , ATSG , BCOV , BFAM , BIO , BL , BLDR , BNFT , BRKR , BVX , CARB , CATM , CBPO , CBS , CC , CCRN , CECO , CERS , CHEF , CNMD , CNXN , CORT , CPS , CPSI ...
News, Short Squeeze, Breakout and More Instantly...
China Biologic Products Holdings Inc. Company Name:
CBPO Stock Symbol:
NASDAQ Market:
China Biologic Products Holdings Inc. Website:
Leading English language training provider Meten Holding Group’s (METX) stock has soared 54.5% in price over the past month thanks to the company’s strategic collaboration with AGM Group Holdings. However, given the company’s negative profit margins and mixed financials, ...
Currently trading at less than $1, the shares of China-based BIMI International Medical’s (BIMI) have dipped 72.2% in price over the past year. So, given the company’s weak financials and poor profitability, will its stock be able to regain its momentum? Read more to find out. ...
China Biologic Announces Completion of Going Private Transaction PR Newswire BEIJING , April 20, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmac...